Alentis Therapeutics

Discussion
https://alentis.ch ↗ LinkedIn ↗

Company facts

Series D+-stage
Founded
2019
Employees
67
Headquarters
SWITZERLANDSWITZERLAND

About

Alentis Therapeutics is a clinical-stage biotechnology company pioneering first-in-class antibody-drug conjugates (ADCs) and antibodies targeting Claudin-1 (CLDN1) for oncology and multi-organ fibrosis. CLDN1 is a previously unexploited target that plays a key role in the pathology of cancer and fibrotic disease. Alent…